Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448544![]() (N-(2-(4-(furan-2-ylmethyl)piperazin-1-yl)-5- (trif...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.370 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448683![]() (N-(2-(4-(thiazol-5-ylmethyl)piperazin-1-yl)-5- (tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448727![]() (5-(tetrahydro-2H-pyran-4-yl)-N-(2-(4-(thiazol-5- y...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448695![]() (N-(2-(4-(furan-3-ylmethyl)piperazin-1-yl)-5- (trif...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448663![]() (N-(2-(4-(oxazol-5-ylmethyl)piperazin-1-yl)-5- (tri...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.760 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448673![]() (N-(5-chloro-2-(4-(furan-2-ylmethyl)piperazin-1-yl)...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448662![]() (N-(2-(4-(oxazol-4-ylmethyl)piperazin-1-yl)-5- (tri...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448675![]() (N-(2-(4-(furan-2-ylmethyl)piperazin-1-yl)-5- (trif...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448664![]() (5-(tetrahydro-2H-pyran-4-yl)-N-(2-(4-(thiazol-4- y...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448697![]() (N-(2-(4-(furan-3-ylmethyl)piperazin-1-yl)-5- (trif...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448726![]() (N-(2-(4-(isoxazol-5-ylmethyl)piperazin-1-yl)-5-(tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448715![]() (N-(2-(4-(isoxazol-5-ylmethyl)piperazin-1-yl)-5-(tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448647![]() (N-(2-(4-((1H-pyrazol-3-yl)methyl)piperazin-1-yl)-5...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448696![]() (N-(2-(4-((5-methylfuran-2-yl)methyl)piperazin-1-yl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448661![]() (N-(2-(4-(oxazol-2-ylmethyl)piperazin-1-yl)-5- (tri...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448729![]() (N-(2-(4-(furan-3-ylmethyl)piperazin-1-yl)-5- (trif...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448717![]() (N-(2-(4-(isoxazol-5-ylmethyl)piperazin-1-yl)-5-(tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM221074![]() (SPHINX31 | US9695160, 12 | US9796707, Compound 12) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid PDB UniChem | PDB Article PubMed | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Exonate Ltd | Assay Description A reaction buffer containing 200 mM Tris pH 7.5, 100 mM MgCl2 and 0.1 mg/ml BSA was added to 43 μM SRSF1Arg-Ser (RS) peptide (NH2-RSPSYGRSRSRSRS... | ACS Chem Biol 12: 825-832 (2017) Article DOI: 10.1021/acschembio.6b01048 BindingDB Entry DOI: 10.7270/Q2K64GXC | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM221074![]() (SPHINX31 | US9695160, 12 | US9796707, Compound 12) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid PDB UniChem | PDB Article PubMed | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Exonate Ltd | Assay Description A reaction buffer containing 200 mM Tris pH 7.5, 100 mM MgCl2 and 0.1 mg/ml BSA was added to 43 μM SRSF1Arg-Ser (RS) peptide (NH2-RSPSYGRSRSRSRS... | ACS Chem Biol 12: 825-832 (2017) Article DOI: 10.1021/acschembio.6b01048 BindingDB Entry DOI: 10.7270/Q2K64GXC | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448682![]() (N-(2-(4-(thiazol-4-ylmethyl)piperazin-1-yl)-5- (tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448674![]() (N-(5-chloro-2-(4-(oxazol-4-ylmethyl)piperazin-1-yl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448723![]() (N-(2-(4-(isoxazol-4-ylmethyl)piperazin-1-yl)-5-(tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448718![]() (US10696661, Compound 65) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448698![]() (5-methyl-N-(2-(4-((5-methylfuran-2-yl)methyl)piper...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448670![]() (N-(2-(4-((1H-pyrazol-3-yl)methyl)piperazin-1-yl)-5...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448672![]() (N-(2-(4-((1-methyl-1H-pyrazol-3-yl)methyl)piperazi...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448684![]() (N-(2-(4-((1H-pyrazol-3-yl)methyl)piperazin-1-yl)-5...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448667![]() (5-(pyridin-4-yl)-N-(2-(4-(thiazol-4-ylmethyl)piper...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 13.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448681![]() (N-(2-(4-(thiazol-2-ylmethyl)piperazin-1-yl)-5- (tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 14.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448548![]() (5-methyl-N-(2-(4-((furan-2-yl)methyl)piperazin-1-y...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 17.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM221072![]() (SPHINX scaffold, 2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Exonate Ltd | Assay Description A reaction buffer containing 200 mM Tris pH 7.5, 100 mM MgCl2 and 0.1 mg/ml BSA was added to 43 μM SRSF1Arg-Ser (RS) peptide (NH2-RSPSYGRSRSRSRS... | ACS Chem Biol 12: 825-832 (2017) Article DOI: 10.1021/acschembio.6b01048 BindingDB Entry DOI: 10.7270/Q2K64GXC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448704![]() (N-(2-(4-(oxazol-4-ylmethyl)piperazin-1-yl)-5-(trif...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448657![]() (N-(2-(4-((5-methylfuran-2-yl)methyl)piperazin-1-yl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 21.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448687![]() (N-(2-(4-(oxazol-4-ylmethyl)piperazin-1-yl)-5- (tri...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 21.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448699![]() (N-(2-(4-(furan-3-ylmethyl)piperazin-1-yl)-5- (trif...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 21.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448685![]() (N-(2-(4-((1-methyl-1H-pyrazol-3-yl)methyl)piperazi...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448680![]() (N-(5-chloro-2-(4-(furan-2-ylmethyl)piperazin-1- yl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 27.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448668![]() (5-(pyridin-4-yl)-N-(2-(5-(thiazol-2-ylmethyl)piper...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 27.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448693![]() (N-(2-(4-(1H-imidazol-4-ylmethyl)piperazin-1-yl)-5-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 28.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448693![]() (N-(2-(4-(1H-imidazol-4-ylmethyl)piperazin-1-yl)-5-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 28.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM221071![]() (SPHINX scaffold, 1) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | Purchase PC cid PC sid PDB UniChem | PDB Article PubMed | n/a | n/a | 31 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Exonate Ltd | Assay Description A reaction buffer containing 200 mM Tris pH 7.5, 100 mM MgCl2 and 0.1 mg/ml BSA was added to 43 μM SRSF1Arg-Ser (RS) peptide (NH2-RSPSYGRSRSRSRS... | ACS Chem Biol 12: 825-832 (2017) Article DOI: 10.1021/acschembio.6b01048 BindingDB Entry DOI: 10.7270/Q2K64GXC | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448690![]() (N-(2-(4-((1H-indol-3-yl)methyl)piperazin-1-yl)-5- ...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448700![]() (N-(2-(4-((5-methylfuran-2-yl)methyl)piperazin-1-yl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 32.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448722![]() (N-(2-(4-(isoxazol-4-ylmethyl)piperazin-1-yl)-5-(tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 33.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448725![]() (N-(2-(4-(isoxazol-4-ylmethyl)piperazin-1-yl)-5- (t...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM221073![]() (SPHINX scaffold, 3 | US9695160, SPHINX7 | US979670...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 36 | n/a | n/a | n/a | n/a | 7.45 | 37 |
Exonate Ltd | Assay Description Whole cell patch clamp recordings of hERG current (IhERG) were made at 37 °C from human embryonic kidney cells (HEK 293) cells stably expressing ... | ACS Chem Biol 12: 825-832 (2017) Article DOI: 10.1021/acschembio.6b01048 BindingDB Entry DOI: 10.7270/Q2K64GXC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448621![]() (N-(2-(4-(thiazol-5-ylmethyl)piperazin-1-yl)-5- (tr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 39.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM221073![]() (SPHINX scaffold, 3 | US9695160, SPHINX7 | US979670...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 59 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Exonate Ltd | Assay Description A reaction buffer containing 200 mM Tris pH 7.5, 100 mM MgCl2 and 0.1 mg/ml BSA was added to 43 μM SRSF1Arg-Ser (RS) peptide (NH2-RSPSYGRSRSRSRS... | ACS Chem Biol 12: 825-832 (2017) Article DOI: 10.1021/acschembio.6b01048 BindingDB Entry DOI: 10.7270/Q2K64GXC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448691![]() (US10696661, Compound 39) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 60.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
SRSF protein kinase 1 (Homo sapiens (Human)) | BDBM448574![]() (N-(2-(4-((1H-pyrazol-3-yl)methyl)piperazin-1-yl)-5...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 62.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Exonate Limited US Patent | Assay Description Screening of a series of molecules identified compounds (Compounds 5, 8, 16 to 18 and 43 of Table 3) that had improved potency against SRPK1 against ... | US Patent US10696661 (2020) BindingDB Entry DOI: 10.7270/Q23B635R | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 78 total ) | Next | Last >> |